projects

Overcoming Barriers to Migrant and Refugee Access and Use of Antibiotics 

Gender equality

Silhouettes of five people walking along a winding path across a world map toward an opening, symbolizing migration journeys and pathways to healthcare access.

By identifying and removing barriers to access and appropriate antibiotic use for migrant and refugee communities, health inequities and drug-resistance can be reduced nationally and globally. 

Background:

Migrant and refugee communities often face heightened infection risks. They can also face limited access to formal health systems and additional legal, financial, and social barriers to care. These barriers increase reliance on informal or inappropriate antibiotic use. Addressing these gaps is essential not only to reducing health inequities, but also to strengthen national and global efforts to contain resistance. 

Researchers
  • Suzanne Garkay Naro
  • Michèle Palkovits
  • Arne Ruckert
  • Andrea Morales Caceres
  • Ranjana Nagi
  • Cordelia Chik
  • Steven J. Hoffman
  • Susan Rogers Van Katwyk

What We Did:

In 2024, researchers at GSL conducted a global rapid scoping review to collect evidence of barriers to access and appropriate use of antibiotics among migrants and refugees. This research includes work completed with the World Health Organization as part of the Global Evidence Review on Health and Migration (GEHM) series.

Key Findings

  • Migrants and refugees experience barriers along the continuum of care from both the patient and health-system side, influencing access to quality-assured and appropriate antibiotics. 
  • Structural and social factors, like language barriers, fear of deportation, discrimination, long waiting times, limited transportation, and previous negative healthcare experiences, reduce trust in formal services, increasing reliance informal antibiotic use. 
  • Health system constraints, such as lack of insurance coverage, diagnostic uncertainty, limited availability of translated services, and substandard medicines, further constrain access to appropriate treatment and contribute to incorrect use of antibiotics.  
Health-system and patient side barriers to antibiotic access and appropriate use along the continuum of care for migrant and refugee populations. This figure illustrates the barriers along the five key dimensions – approachability, acceptability, availability and accommodation, affordability, and appropriateness – which influence antibiotic access and appropriate use for migrant and refugee populations along the continuum of care from the patient-side and health-system side factors
  • The study proposes global policy recommendations such as including refugees and migrants into WHO’s Global Action Plan on AMR to promote an equity-focused framework for coordinated action. 
  • National policy recommendations from this study include expanding language support, culturally tailored health education, and health literacy programs to promote access to appropriate antibiotic use. 

Outputs

This global rapid scoping review, published in BMC Globalization and Health, collects evidence on how systematic, social and financial barriers play a role in antibiotic access and use among migrant and refugee populations.

The fourth report of the Global Evidence Review on Health and Migration (GEHM) series synthesizes available evidence on access to essential antibiotics in refugee and migrant populations. The report captures evidence across four themes related to antibiotic access and use: access, appropriate use, barriers to access and use, and interventions to improve access and use.

This visual resource highlights how structural, social, and health system barriers shape antibiotic access and use among migrant and refugee populations.

Join our Mailing List

This field is for validation purposes and should be left unchanged.

Previous

February 1, 2026

Advancing Tobacco Control Through Gender Data 

Next

May 15, 2026

Adapting Gender Equality Frameworks in Humanitarian Response